LMAT Q3 2024 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$55M+15.6% YoY

Gross Profit

$37M67.8% margin

Operating Income

$13M24.0% margin

Net Income

$11M20.3% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$377M

Total Liabilities

$46M

Stockholders' Equity

$331M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$47M	+15.6%
Gross Profit	$37M	$31M	+20.6%
Operating Income	$13M	$9M	+43.2%
Net Income	$11M	$8M	+48.5%

Geographic Segments

Americas

$36M65%

EMEA

$15M27%

Asia Pacific

$4M7%